- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Diphtheria Toxin-Based Therapy: A Review Article
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-18
DOI
10.3389/fmicb.2019.02340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti–PD-1 in melanoma
- (2019) Laurene S. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tagraxofusp: First Global Approval
- (2019) Yahiya Y. Syed DRUGS
- E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study
- (2018) Ken Ohmachi et al. CANCER SCIENCE
- First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
- (2018) Weili Sun et al. Journal of Hematology & Oncology
- Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy
- (2018) Yu Chen et al. Cell Death & Disease
- Anti-cancer binary system activated by bacteriophage HK022 integrase
- (2018) Amer Elias et al. Oncotarget
- Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell Malignancies
- (2018) Joerg Schmohl et al. Toxins
- Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect
- (2018) Chao Chen et al. Molecular Therapy-Nucleic Acids
- Moxetumomab Pasudotox: First Global Approval
- (2018) Sohita Dhillon DRUGS
- Design of a recombinant immunotoxin against the human granulocyte-colony stimulating factor receptor
- (2018) E. Babavalian et al. MOLECULAR BIOLOGY REPORTS
- Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
- (2017) Yuan Yu et al. International Journal of Nanomedicine
- Recombinant Production and Intein-Mediated Purification of an Antimicrobial Peptide, BR2
- (2017) Fatemeh Shafiee et al. International Journal of Peptide Research and Therapeutics
- Ontak-like human IL-2 fusion toxin
- (2017) Zhaohui Wang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Diphtheria toxin-based anti-human CD19 immunotoxin for targeting human CD19+ tumors
- (2017) Qian Zheng et al. Molecular Oncology
- Production and evaluation of cytotoxic effects of DT386-BR2 fusion protein as a novel anti-cancer agent
- (2016) Fatemeh Shafiee et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
- (2016) Nathan Simon et al. Toxins
- A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression
- (2015) Jie Meng et al. CANCER BIOLOGY & THERAPY
- Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies
- (2015) V. Bachanova et al. CLINICAL CANCER RESEARCH
- Resimmune, an anti-CD3 recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma
- (2015) A. E. Frankel et al. HAEMATOLOGICA
- Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A
- (2015) Baoshun Lin et al. MEDICINE
- Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4+ cells in vivo
- (2015) Zhaohui Wang et al. Molecular Oncology
- Treg depletion in non-human primates using a novel diphtheria toxin-based anti-human CCR4 immunotoxin
- (2015) Zhaohui Wang et al. Molecular Oncology
- Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development
- (2015) Joerg U. Schmohl et al. Toxins
- Resimmune, an anti-CD3 recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma
- (2015) A. E. Frankel et al. HAEMATOLOGICA
- Utilization of Rad51C promoter for transcriptional targeting of cancer cells
- (2015) Yan Cao et al. Oncotarget
- Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
- (2014) A. E. Frankel et al. BLOOD
- Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25+ cells
- (2014) Jaclyn Stromp Peraino et al. JOURNAL OF IMMUNOLOGICAL METHODS
- MSN Anti-Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis Inhibition
- (2013) Qianjun He et al. ADVANCED MATERIALS
- Survivin Status Affects Prognosis and Chemosensitivity in Epithelial Ovarian Cancer
- (2013) Lifeng Chen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer
- (2013) Ofer N. Gofrit et al. JOURNAL OF UROLOGY
- Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis
- (2013) Ping Chen et al. MEDICAL ONCOLOGY
- A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells
- (2013) Ki Jung Lim et al. PLoS One
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Attempts to Express the A1-GMCSF Immunotoxin in the Baculovirus Expression Vector System
- (2012) Ali JAHANIAN-NAJAFABADI et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer
- (2012) N Hanna et al. CANCER GENE THERAPY
- TFF3 and survivin expressions associate with a lower survival rate in gastric cancer
- (2012) Jia-Rong Meng et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Diphtheria Toxin-Epidermal Growth Factor Fusion Protein DAB389EGF for the Treatment of Bladder Cancer
- (2012) X. Yang et al. CLINICAL CANCER RESEARCH
- The many faces and functions of β-catenin
- (2012) Tomas Valenta et al. EMBO JOURNAL
- Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer
- (2012) Jun Huang et al. JOURNAL OF NEURO-ONCOLOGY
- Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells
- (2012) D.-K. Chang et al. MOLECULAR CANCER THERAPEUTICS
- DT390-triTMTP1, a Novel Fusion Protein of Diphtheria Toxin with Tandem Repeat TMTP1 Peptide, Preferentially Targets Metastatic Tumors
- (2012) Xiangyi Ma et al. MOLECULAR PHARMACEUTICS
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer
- (2011) Tracy R. Daniels et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Regional therapy with DTA-H19 vector suppresses growth of colon adenocarcinoma metastases in the rat liver
- (2011) Vladimir Sorin INTERNATIONAL JOURNAL OF ONCOLOGY
- CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis
- (2011) Peng Xu et al. MEDICAL ONCOLOGY
- Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity
- (2011) Y. Cao et al. MOLECULAR CANCER THERAPEUTICS
- Rad51 Promoter-Targeted Gene Therapy Is Effective for In Vivo Visualization and Treatment of Cancer
- (2011) Christopher M Hine et al. MOLECULAR THERAPY
- Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth
- (2011) Günther Hasenpusch et al. PLoS One
- A Novel Fusion Protein Diphtheria Toxin–Stem Cell Factor (DT-SCF)—Purification and Characterization
- (2010) Sirisha Potala et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Intratumoral Therapy of Glioblastoma Multiforme Using Genetically Engineered Transferrin for Drug Delivery
- (2010) Dennis J. Yoon et al. CANCER RESEARCH
- Development of Chimeric Gene Regulators for Cancer-specific Gene Therapy with both Transcriptional and Translational Targeting
- (2010) Yu Xiang Fang et al. MOLECULAR BIOTECHNOLOGY
- A New Drug Delivery Method of Bispecific Ligand-Directed Toxins, Which Reduces Toxicity and Promotes Efficacy in a Model of Orthotopic Pancreatic Cancer
- (2010) Seunguk Oh et al. PANCREAS
- Toxin-Based Therapeutic Approaches
- (2010) Assaf Shapira et al. Toxins
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
- (2009) Laurent Ducry et al. BIOCONJUGATE CHEMISTRY
- Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy
- (2009) P Fogar et al. CANCER GENE THERAPY
- Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin
- (2009) Robert Sarnovsky et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma
- (2009) A. Frankel et al. CURRENT DRUG TARGETS
- IL-13 receptor-α2: a novel target for cancer therapy
- (2009) Bharat H Joshi et al. Immunotherapy
- Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery
- (2009) Seunguk Oh et al. JOURNAL OF NEURO-ONCOLOGY
- Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
- (2009) Aya Mizrahi et al. Journal of Translational Medicine
- Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy
- (2009) Daniel A. Vallera et al. LEUKEMIA RESEARCH
- Buforins: Histone H2A-derived antimicrobial peptides from toad stomach
- (2008) Ju Hyun Cho et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice
- (2008) D. J. McCrann et al. BLOOD
- Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1)
- (2008) Jung Hee Woo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide
- (2008) Hyun Soo Lee et al. CANCER LETTERS
- TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis
- (2008) W. Yang et al. CLINICAL CANCER RESEARCH
- Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
- (2008) D. A. Vallera et al. GUT
- Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin
- (2008) Abraham Ami Sidi et al. JOURNAL OF UROLOGY
- Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia
- (2008) Arthur Frankel et al. LEUKEMIA & LYMPHOMA
- Use of the Rad51 promoter for targeted anti-cancer therapy
- (2008) C. M. Hine et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials
- (2007) Jung Hee Woo et al. PROTEIN EXPRESSION AND PURIFICATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now